Semaglutide’s U.S. patents keep generics out until around 2031 or 2035, maintaining Novo Nordisk’s exclusivity and high ...

The Supreme Court agreed to review a controversy over so-called skinny labels for medicines, a decision that will be closely ...

We’ve launched a first-of-its-kind app to help you find out where your generic drugs come from and see the track records of ...

The ​Association for Accessible Medicines, which represents generic drugmakers, is expanding its roster of hired guns.

The Food and Drug Administration on Monday announced it had approved generic versions of Vyvanse, an increasingly popular alternative to Adderall. Commonly prescribed ...

According to Nuvama, the increased competitive intensity following this approval is negative for Cipla, as it raises the risk ...

Health Canada is reviewing nine submissions for generic versions of semaglutide, a prescription medication sold under Novo ...

Every week through October, we are examining the medical, business and cultural systems that contribute to the dichotomy that is the American health care system — a system that benefits some but costs ...

The Medicare Part D program would have saved $977 million in a single year if all branded prescription drugs requested by prescribing clinicians had been substituted by a generic option, according to ...

Officials with the FDA have approved the first generic robenacoxib tablets for the control of postoperative pain and ...